Question 1

What is SIGA's history of partnerships?

Accepted Answer

SIGA has a rich history of successful partnerships to support its vision of providing solutions for unmet needs in health security.

Question 2

What is the size of the health security market that SIGA operates in?

Accepted Answer

The health security market that SIGA operates in is a $

Question 3

What is SIGA's main product?

Accepted Answer

SIGA's main product is TPOXX (tecovirimat-SIGA), which is approved for the treatment of smallpox by the U.S. FDA and Health Canada, and for the treatment of monkeypox, cowpox, smallpox, and complications from vaccinia virus by the EMA and MHRA.

Question 4

What is SIGA's focus as a company?

Accepted Answer

SIGA is a public, commercial-stage pharmaceutical company focused on providing solutions for unmet needs in health security. This includes developing medical countermeasures for biological, chemical, radiological and nuclear attacks, as well as vaccines, therapeutics and diagnostics for emerging infectious diseases.

Question 5

What markets does SIGA's product TPOXX serve?

Accepted Answer

TPOXX is approved for the treatment of smallpox in the United States and Canada, and for the treatment of monkeypox, cowpox, smallpox, and complications from vaccinia virus in Europe.

SIGA

Company Overview

Company Name

Address

Website

Phone

About SIGA

Frequently Asked Questions about SIGA

What is SIGA's history of partnerships?

What is the size of the health security market that SIGA operates in?

What is SIGA's main product?

What is SIGA's focus as a company?

What markets does SIGA's product TPOXX serve?

Technologies Used

Social Profiles

Key Decision Makers